A study to investigate the residual effects of ramelteon (8 mg), zopiclone (7.5 mg) and placebo on actual driving, memory, psychomotor performance and mood.

Trial Profile

A study to investigate the residual effects of ramelteon (8 mg), zopiclone (7.5 mg) and placebo on actual driving, memory, psychomotor performance and mood.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2013

At a glance

  • Drugs Ramelteon; Zopiclone
  • Indications Anxiety disorders; Sleep disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Jun 2009 Results presented at the 9th World Congress of Biological Psychiatry.
    • 09 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top